About Aurobindo Pharma Foundation
Data last updated:
Aurobindo Pharma Foundation is a private not for profit company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It operates in the animal health services segment of the veterinary services sector. It was incorporated on 20 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85200TG2020NPL141954.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nityananda Reddy Kambam and Sivakumaran Meenakshisunderam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.45 Cr, a decline of 8% compared to the previous year. For the same year it recorded EBITDA of ₹12 Lakh (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The company has about 18 employees on its provident fund (EPFO) records.
For more details, the company can be reached via its website aurobindo.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryVeterinary, Animal Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Aurobindo Pharma Foundation FY 2025 filings available
Aurobindo Pharma Foundation reported revenue of ₹50.45 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aurobindo Pharma Foundation
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 8% fall in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aurobindo Pharma Foundation
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aurobindo Pharma Foundation
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aurobindo Pharma Foundation are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Aurobindo Pharma Foundation
Aurobindo Pharma Foundation is audited by G P M & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aurobindo Pharma Foundation
Aurobindo Pharma Foundation has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nityananda Reddy Kambam Also directs: Aurobindo Pharma Ltd, Aurobindo Antibiotics Private Limited, Apl Healthcare Limited and 5 more | Director | 20 Jul 2020 | 6 Years 2 Months | Current |
| Sivakumaran Meenakshisunderam Also directs: Apl Healthcare Limited, Curateq Biologics Private Limited, Tergene Biotech Limited and 2 more | Director | 20 Jul 2020 | 6 Years 2 Months | Current |
| Sarath Chandra Reddy Penaka Also directs: Aurobindo Pharma Ltd, Sarath Penaka Enterprises LLP, Naqsh Global Ventures LLP and 4 more | Director | 20 Jul 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Aurobindo Pharma Foundation
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aurobindo Pharma Foundation
Aurobindo Pharma Foundation does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aurobindo Pharma Foundation
Aurobindo Pharma Foundation has a workforce of 18 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Aurobindo Pharma Foundation
Recent Activity on Aurobindo Pharma Foundation
Aurobindo Pharma Foundation has 3 board changes on record since 2020: 3 appointments. The latest: Nityananda Reddy Kambam was appointed as Director on 20 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Aurobindo Pharma Foundation
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aurobindo Pharma Foundation
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aurobindo Pharma Foundation
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aurobindo Pharma Foundation
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aurobindo Pharma Foundation
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurobindo Pharma Foundation
Aurobindo Pharma Foundation is an active private not for profit company based in Hyderabad, Telangana, India. The company works in animal health services, within the veterinary industry. It was incorporated on 20 July 2020 (6+ years old) and is registered under CIN U85200TG2020NPL141954.
Aurobindo Pharma Foundation reported revenue of ₹50.45 Cr for FY 2025 (down 8% YoY).
Aurobindo Pharma Foundation has 3 current directors:
- Nityananda Reddy Kambam - Director
- Sivakumaran Meenakshisunderam - Director
- Sarath Chandra Reddy Penaka - Director
Aurobindo Pharma Foundation reported EBITDA of ₹12 Lakh (EBITDA margin 0.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aurobindo Pharma Foundation is -2% over three years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Aurobindo Pharma Foundation is U85200TG2020NPL141954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurobindo Pharma Foundation was incorporated on 20 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nityananda Reddy Kambam was appointed as Director on 20 Jul 2020. Sarath Chandra Reddy Penaka was appointed as Director on 20 Jul 2020. Sivakumaran Meenakshisunderam was appointed as Director on 20 Jul 2020.
Aurobindo Pharma Foundation can be reached through the website aurobindo.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Aurobindo Pharma Foundation is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.